Symbiofarm Krok sp. k.

Manufacture of food supplements

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-02-10
Limited partner contribution
5,000.00 PLN
Activity description

Symbiofarm Krok contract-manufactures dietary supplements, from simple preparations to complex multi-ingredient and liposomal formulas. It offers hard and soft capsules, sachets and liquids, as well as packaging in blisters, cartons and bottles.

Registered address
160, 38-120 Nowa Wieś, Poland
Branches
  • ul. Nowa Wieś 160, 38-120 Czudec
  • ul. Spółdzielcza 1, 38-100 Strzyżów
Email
Phone

Financials

Filing timeliness

The financial statement for 2025 was filed on time.

  • 202515/07/2026
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 9.7%
Division · Manufacture of food products648 / 3,403
Top 19%
Sector · Manufacturing3,002 / 24,548
Top 12%
Voivodeship · Podkarpackie405 / 10,779
Top 3.8%
Country · Poland12,373 / 297,069
Top 4.2%

Results vs industry

Revenue
This companyUSD 16.92mMedianUSD 284.01kAverageUSD 6.97m
Net profit
This companyUSD 3.17mMedianUSD 4.93kAverageUSD 683.78k
Operating costs
This companyUSD 12.75mMedianUSD 387.31kAverageUSD 6.05m
Assets
This companyUSD 10.15mMedianUSD 349.52kAverageUSD 6.87m

Offer

Authorized Representatives

Michał Tomczyk age 27 – Attorney-in-fact (sole)

Manner of representation

Each of the general partners acting independently is authorized to represent the company. The authorization to represent covers all judicial and extrajudicial acts.

Bank accounts

Registered as a VAT taxpayer on 2011-10-11.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$230.9K

Public aid

20 public aid cases recorded, with a total value of $158,307.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–

European Funds

ProjectEU co-financing
Export development of SYMBIOFARM Sp. z o.o.
$89,005

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Prosuplement Group sp. z o.o.
Curtis Health Caps S.A.
Exim Pharma sp. z o.o.
Global Pharma Cm S.A.
Europharma Alliance sp. z o.o.
Laboratoria Natury sp. z o.o.
Ośrodek Badawczo-Produkcyjny Politechniki Łódzkiej Ichem sp. z o.o.
All4pharmacy sp. z o.o.
Tantus sp. z o.o.
Supplelab sp. z o.o. + limited partnership

FAQ

Last updated: 2026-10-21